Targeting other key pathways together with SHH signaling is a potential strategy, as there is considerable heterogeneity among SHH subgroup MB, suggesting that non-transcriptional mechanisms are also involved in SHH-signaling-mediated tumorigenesis in medulloblastoma [120]. Here, SHH is linked to medulloblastoma.